A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials

Saba S. Shaikh; Priya U. Kumthekar; Nisha A. Mohindra

doi:10.1007/s11060-019-03219-7

A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials

Saba S. Shaikh^*, Priya U. Kumthekar, Nisha A. Mohindra

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	235-237
Number of pages	3
Journal	Journal of Neuro-Oncology
Volume	144
Issue number	1
DOIs	https://doi.org/10.1007/s11060-019-03219-7
State	Published - Aug 15 2019

ASJC Scopus subject areas

Oncology
Neurology
Clinical Neurology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11060-019-03219-7

Cite this

@article{31c4fcafd78846a298498b2f3d040daa,

title = "A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials",

author = "Shaikh, {Saba S.} and Kumthekar, {Priya U.} and Mohindra, {Nisha A.}",

year = "2019",

month = aug,

day = "15",

doi = "10.1007/s11060-019-03219-7",

language = "English (US)",

volume = "144",

pages = "235--237",

journal = "Journal of Neuro-Oncology",

issn = "0167-594X",

publisher = "Kluwer Academic Publishers",

number = "1",

}

TY - JOUR

T1 - A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials

AU - Shaikh, Saba S.

AU - Kumthekar, Priya U.

AU - Mohindra, Nisha A.

PY - 2019/8/15

Y1 - 2019/8/15

UR - http://www.scopus.com/inward/record.url?scp=85068308501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068308501&partnerID=8YFLogxK

U2 - 10.1007/s11060-019-03219-7

DO - 10.1007/s11060-019-03219-7

M3 - Letter

C2 - 31240523

AN - SCOPUS:85068308501

SN - 0167-594X

VL - 144

SP - 235

EP - 237

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

IS - 1

ER -

A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this